Last edition
News about Global Pharma
Gujarat Alkalies and Chemicals Limited (GACL) Flags Off the first dispatch of import substitute Hydrazine Hydrate and Purified Phosphoric Acid<br />
Global Pharma | 11/07/2023 | By Sudeep Soparkar | 1202
Aarti Drugs Limited wins Pharmexcil Outstanding Exports Awards 2021-22
Aarti Drugs Limited wins Pharmexcil Outstanding Exports Awards 2021-22
Global Pharma | 10/07/2023 | By Sudeep Soparkar | 1054
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
Global Pharma | 28/06/2023 | By Sudeep Soparkar | 936
Aurobindo Pharma Ltd's subsidiary to withdraw application for EU Marketing Authorization of two biosimilars
Global Pharma | 26/06/2023 | By Sudeep Soparkar | 1172
Dr Mansukh Mandaviya addresses IPA’s 8th Global Pharmaceutical Quality Summit: Focus on Patient Centricity and the Future of Manufacturing and Quality
Global Pharma | 26/06/2023 | By Sudeep Soparkar | 763
H.E.L Group Unveils New State-of-the-Art Global Headquarters to Drive Innovation and Collaboration
Overseen by interim Operational Director, Damian Slater, the move to new purpose-designed facilities supports the Company’s continued expansion and plans for future growth.
Global Pharma | 20/06/2023 | By Manvi | 751
Steriline and INCOME, two renowned names synonymous with quality and service in the Indian pharmaceutical industry for the past three decades, announce the establishment of Steriline Asia Pvt. Ltd. This strategic move aims to enhance their footprint on the Indian subcontinent and cater to the evolving needs of the industry.
Global Pharma | 07/06/2023 | By Manvi | 1849
China's Fosun to build African drug manufacturing plant with help from World Bank
China’s Fosun Pharma plans to build a facility in the Ivory Coast to manufacture anti-malaria drugs and antibacterial medicines with the help of a 100 million euro ($106 million) loan from the International Finance Corporation (IFC).
Global Pharma | 07/06/2023 | By Sudeep Soparkar | 844
Laurus Labs to increase stake in ImmunoACT to 33.86%
Laurus Labs to increase stake in ImmunoACT to 33.86%
Global Pharma | 01/06/2023 | By Sudeep Soparkar | 742
UCB Pharma Receives FDA Form 483 in Belgium
The FDA issued a Form 483 to UCB Pharma, a biopharma business with headquarters in Belgium after an examination revealed problems with its quality control unit and product storage.
Global Pharma | 31/05/2023 | By Manvi | 2175
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy